A US import levy on pharmaceuticals would be a blow to India’s economy but far from a fatal one: pharmaceuticals have been a longstanding strong-point in India's export sector but they have been overtaken by electronics in recent years.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services